134 related articles for article (PubMed ID: 17883632)
1. Extracorporeal circuit pressure profiles during continuous venovenous haemofiltration.
Ejaz AA; Komorski RM; Ellis GH; Munjal S
Nurs Crit Care; 2007; 12(2):81-5. PubMed ID: 17883632
[TBL] [Abstract][Full Text] [Related]
2. Real-time circuit pressures correlate poorly with circuit longevity in anticoagulant-free, predilution continuous venovenous hemofiltration.
Tan CS; Tan HK; Choong HL
Blood Purif; 2011; 32(1):15-20. PubMed ID: 21252502
[TBL] [Abstract][Full Text] [Related]
3. Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations.
Munjal S; Ejaz AA
Nephrology (Carlton); 2006 Oct; 11(5):405-9. PubMed ID: 17014553
[TBL] [Abstract][Full Text] [Related]
4. Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent.
Fiaccadori E; Maggiore U; Rotelli C; Minari M; Melfa L; Cappè G; Cabassi A
Intensive Care Med; 2002 May; 28(5):586-93. PubMed ID: 12029407
[TBL] [Abstract][Full Text] [Related]
5. Regional anticoagulation and antiaggregation for CVVH in critically ill patients: a prospective, randomized, controlled pilot study.
Fabbri LP; Nucera M; Al Malyan M; Becchi C
Acta Anaesthesiol Scand; 2010 Jan; 54(1):92-7. PubMed ID: 19650808
[TBL] [Abstract][Full Text] [Related]
6. Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH--an in vitro study.
Unger JK; Haltern C; Portz B; Dohmen B; Gressner A; Rossaint R
Nephrol Dial Transplant; 2006 Aug; 21(8):2191-201. PubMed ID: 16567341
[TBL] [Abstract][Full Text] [Related]
7. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
Bihorac A; Ross EA
Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732
[TBL] [Abstract][Full Text] [Related]
8. The use of regional citrate anticoagulation continuous venovenous hemofiltration in extracorporeal membrane oxygenation.
Shum HP; Kwan AM; Chan KC; Yan WW
ASAIO J; 2014; 60(4):413-8. PubMed ID: 24727536
[TBL] [Abstract][Full Text] [Related]
9. The effect of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration.
Fealy N; Baldwin I; Bellomo R
Crit Care Resusc; 2002 Dec; 4(4):266-70. PubMed ID: 16573439
[TBL] [Abstract][Full Text] [Related]
10. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution.
Shum HP; Chan KC; Yan WW
Ther Apher Dial; 2012 Feb; 16(1):81-6. PubMed ID: 22248200
[TBL] [Abstract][Full Text] [Related]
11. Continuous venovenous hemofiltration with or without extracorporeal membrane oxygenation in children.
Shaheen IS; Harvey B; Watson AR; Pandya HC; Mayer A; Thomas D
Pediatr Crit Care Med; 2007 Jul; 8(4):362-5. PubMed ID: 17545928
[TBL] [Abstract][Full Text] [Related]
12. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis.
de Pont AC; Bouman CS; Bakhtiari K; Schaap MC; Nieuwland R; Sturk A; Hutten BA; de Jonge E; Vroom MB; Meijers JC; Büller HR
ASAIO J; 2006; 52(4):416-22. PubMed ID: 16883122
[TBL] [Abstract][Full Text] [Related]
13. Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration.
Gattringer R; Meyer B; Heinz G; Guttmann C; Zeitlinger M; Joukhadar C; Dittrich P; Thalhammer F
J Antimicrob Chemother; 2006 Aug; 58(2):367-71. PubMed ID: 16782745
[TBL] [Abstract][Full Text] [Related]
14. [Effect of different connection schemes of continuous renal replacement therapy and extracorporeal membrane oxygenation on arterial and venous pressure: an in vitro and in vivo study].
Wang J; Xu Q; Li J; Wang T; Zhong C; Chen Q; Fang K; Jiang H; Zhang P; Lu W; Jiang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):388-393. PubMed ID: 35692204
[TBL] [Abstract][Full Text] [Related]
15. Membrane pressures predict clotting of pediatric continuous renal replacement therapy circuits.
Kakajiwala A; Jemielita T; Hughes JZ; Windt K; Denburg M; Goldstein SL; Laskin B
Pediatr Nephrol; 2017 Jul; 32(7):1251-1261. PubMed ID: 28247082
[TBL] [Abstract][Full Text] [Related]
16. Regional cooling of the extracorporeal blood circuit: a novel anticoagulation approach for renal replacement therapy?
Krouzecky A; Chvojka J; Sykora R; Radej J; Karvunidis T; Novak I; Ruzicka J; Petrankova Z; Benes J; Bolek L; Matejovic M
Intensive Care Med; 2009 Feb; 35(2):364-70. PubMed ID: 18802685
[TBL] [Abstract][Full Text] [Related]
17. Automated electronic monitoring of circuit pressures during continuous renal replacement therapy: a technical report.
Zhang L; Baldwin I; Zhu G; Tanaka A; Bellomo R
Crit Care Resusc; 2015 Mar; 17(1):51-4. PubMed ID: 25702763
[TBL] [Abstract][Full Text] [Related]
18. Assessment of temporary dialysis catheter performance on the basis of flow and pressure measurements in vivo and in vitro.
Kindgen-Milles D; Kram R; Kleinekofort W
ASAIO J; 2007; 53(3):351-6. PubMed ID: 17515728
[TBL] [Abstract][Full Text] [Related]
19. Continuous hemofiltration: nursing perspectives in critical care.
Baldwin IC; Elderkin TD
New Horiz; 1995 Nov; 3(4):738-47. PubMed ID: 8574605
[TBL] [Abstract][Full Text] [Related]
20. Shortened hemofilter survival time due to lipid infusion in continuous renal replacement therapy.
Kazory A; Clapp WL; Ejaz AA; Ross EA
Nephron Clin Pract; 2008; 108(1):c5-9. PubMed ID: 18059111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
